In an IFOM interview, MErCuRIC researcher Prof. Alberto Bardelli of the Universita Degli Studi di Torino talks about why he studies colorectal cancer. He describes personalised medicine, targeted therapies and resistance to therapy, as well as monitoring therapy in real time with blood-based assays called liquid biopsies. You can watch the interview here.
This author has yet to write their bio.Meanwhile lets just say that we are proud mercuric contributed a whooping 50 entries.
Entries by mercuric
Educational videos from Cancer Research for Personalized Medicine (CARPEM) are now available online in French (English subtitles). Pr. Julien Taieb, gastrointestinal oncologist at the Georges Pompidou European Hospital (APHP), describes how advances in personalized medicine modify its practices in the treatment of digestive cancers.
MErCuRIC will be presented at the American Society of Clinical Oncology (ASCO) 2015 meeting, 29 May – 02 June 2015, in Chicago. A poster entitled ‘MErCuRIC1: A Phase I study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor crizotinib in RASMT and RASWT (with aberrant c-MET) metastatic colorectal cancer (mCRC) patients’ will be included in the Gastrointestinal (Colorectal) Cancer […]
The Centre for Cancer Research and Cell Biology at Queen’s University Belfast, in conjunction with the Ireland-Northern Ireland-National Cancer Institute Consortium, will host the All-Ireland Cancer Consortium (AICC) Conference 2015 at the Riddel Hall, Queen’s University Belfast, between 10th and 13th May 2015. The focus of the conference will be on ‘New Horizons for Cancer: Removing […]
MErCuRIC partners attended a successful meeting in VHIO, Barcelona on 16 Dec 2014. Progress made by the consortium in year 1 was discussed and work for year 2 was planned. To date, we have received ethical approval to open two sites (OXFORD and UZA) to recruit to the Phase I trial, and advanced the translational […]
We have new promotional material now available to view in our media area. Follow this link to view our latest flyer.
The NI Cancer Research Forum invite you to a free bowel cancer public information evening. Hear about new developments in Research and Care. Tuesday 2nd December 2014 Belfast City Hospital, Cancer Centre, Level 1, Seminar Room 3, 7-9pm Refreshments will be served. Please contact if interested: email@example.com Tel: 028 90 638468
The MerCuRIC project was covered on UTV television’s UTV Live News programme and website on 11 December, including an interview with Prof Mark Lawler of QUB. Full Article Here: http://www.u.tv/News/Queens-announces-major-cancer-study/7ccf6333-ea82-432f-ad13-6fb84aa0931f
Available to download here. Queen’s leads €6million European study to combat bowel cancer Queen’s University has announced it is to lead a €6 million European study to find new treatments for bowel cancer. The research, which involves 13 partners in eight different European countries, will look at two major genetic factors which make bowel cancer […]
Thank you very much for visiting our new website for the MErCuRIC project. We’ll be updating the site over the next few weeks.
- ‘Trialling tailored treatments for colorectal cancer’: A European Commission Research & Innovation Success StoryApril 16, 2018 - 10:46 am
- MErCuRIC study published in Molecular Cancer TherapeuticsMarch 6, 2018 - 10:14 am
- MErCuRIC team from RECETOX, Masarykova Univerzita publish study resultsMarch 5, 2018 - 9:11 am
MErCuRIC is funded by the European Community’s Framework Programme Seven (FP7) under contract #602901. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.